Private Management Group Inc. Cuts Position in Bausch Health Companies Inc. (NYSE:BHC)

Private Management Group Inc. decreased its position in Bausch Health Companies Inc. (NYSE:BHC) by 15.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,265,250 shares of the company’s stock after selling 227,813 shares during the quarter. Private Management Group Inc. owned 0.35% of Bausch Health Companies worth $10,198,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in BHC. DGS Capital Management LLC acquired a new stake in shares of Bausch Health Companies in the 4th quarter valued at $143,000. Merit Financial Group LLC acquired a new stake in Bausch Health Companies in the fourth quarter valued at $228,000. Sanders Morris Harris LLC lifted its holdings in Bausch Health Companies by 16.0% during the 4th quarter. Sanders Morris Harris LLC now owns 28,975 shares of the company’s stock worth $234,000 after buying an additional 4,000 shares during the last quarter. Northwest & Ethical Investments L.P. lifted its holdings in Bausch Health Companies by 13.0% during the 3rd quarter. Northwest & Ethical Investments L.P. now owns 32,384 shares of the company’s stock worth $264,000 after buying an additional 3,734 shares during the last quarter. Finally, Creative Planning boosted its position in shares of Bausch Health Companies by 16.9% during the 3rd quarter. Creative Planning now owns 55,351 shares of the company’s stock worth $452,000 after acquiring an additional 7,995 shares in the last quarter. Hedge funds and other institutional investors own 78.65% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on BHC shares. StockNews.com upgraded Bausch Health Companies from a “hold” rating to a “buy” rating in a research note on Friday, October 25th. Royal Bank of Canada reduced their price objective on shares of Bausch Health Companies from $11.00 to $10.00 and set a “sector perform” rating for the company in a research report on Thursday, January 30th. Finally, Evercore ISI upgraded shares of Bausch Health Companies to a “hold” rating in a report on Tuesday, October 15th. One analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Bausch Health Companies presently has an average rating of “Hold” and an average price target of $7.58.

Bausch Health Companies Trading Up 1.2 %

BHC stock opened at $7.35 on Thursday. The company has a market capitalization of $2.66 billion, a P/E ratio of -15.30 and a beta of 0.68. The business has a 50 day simple moving average of $7.72 and a 200-day simple moving average of $7.46. Bausch Health Companies Inc. has a twelve month low of $3.96 and a twelve month high of $11.46.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.